baber/WOPTO huggingface dataset:
Patent AU-2013209270-A1 (AU)
Title: A dental wedge
Inventor: ERSKINE-SMITH CRAIG MATHEW
IPC: A61C5/00
Filed: 2013-01-09
Abstract: A dental wedge (10) having a wedge body (11) and a gripping portion (12). The wedge (10) also has a longitudinal axis (13). The body (11) extends from a first end (14) to a second end (15), with the gripping portion (12) attached to the first end (15). The body (11) is constructed of at least two longitudinally extending layers. In one embodiment there are three layers, a first longitudinally extending layer (16), and second longitudinally extending layer (17) and a third longitudinally extending layer (18). The layer (17) is located between the layers (16, 18). In one embodiment the layers (16, 18) are formed of a softer material than the layer (17). In an alternative embodiment the layers (16, 18) are formed of a harder material than the material forming the layer (17).
Patent AU-2013224762-A1 (AU)
Title: Multipole ion guide interface for reduced background noise in mass spectrometry
Inventor: WHITEHOUSE CRAIG M
IPC: H01J49/28
Filed: 2013-09-09
Abstract: Ions that are transported from an ion source to a mass spectrometer for mass analysis are often accompanied by background particles such as photons, neutral species, and cluster or aerosol ions, which originate in the ion source. Background particles are also produced by scattering and neutralization of ions during collisions with background gas molecules in higher pressure regions with line-of-sight to the mass spectrometer detector. In either case, such background particles produce noise in mass spectra Apparatus and methods are provided in which a multipole ion guide is configured to efficiently transport ions through multiple vacuum stages, while preventing background particles, produced both in the ion source and along the ion transport pathway, from reaching the detector, thereby improving signal-to noise in mass spectra. Fig 1
Patent AU-2013225609-A1 (AU)
Title: Agrochemical emulsifiable concentrate formulation
Inventor: BROWN ROWAN
IPC: A01N25/02
Filed: 2013-02-25
Abstract: An agrochemical emulsifiable concentrate (EC) formulation comprising at least one agrochemical active ingredient; at least one surfactant emulsifier; optionally, a stabiliser; and a primary solvent system, wherein the solvent system is selected from benzyl acetate or a combination of benzyl acetate and at least one substantially water-immiscible co-solvent.
Patent AU-2013228015-A1 (AU)
Title: Method for displaying camera preview screen in a portable terminal
Inventor: JANG JONG-WOON
IPC: G06F3/147
Filed: 2013-09-12
Abstract: A method for displaying a camera preview screen of a portable terminal is provided. The method includes displaying a camera preview screen at the preset output frame rate when starting an image capture mode, confirming whether the output frame rate change condition is satisfied, and displaying the camera preview screen at the changed output frame rate when confirmed that the change condition is satisfied. 4688258 _1 (GHMatters) P94793.AU 12/09/13 CORRESPONDING START NO IS IMAGE CAPTURE MODE STARTED? DISPLAY PREVIEW SCREEN AT PRESET OUTPUT FRAME RATE S202 IS OUTPUT FRAMESNO RATE CHANGE CONDITION ON PREVIEW SCREEN SET TO-BE-CHANGED OUTPUT S204 FRAME RATE S0 IS CURRENTLY SET YES OUTPUT FRAME RATE IDENTICAL TO TO-BE-CHANGED OUTPUT FRM ATE? SET PREVIEW SCREEN TO BE DISPLAYED AT TO-BE-CHANGED OUTPUT FRAME S206 RATE BY APPLYING OUTPUT FRAME RATE NO IS IMAGE CAPTURING MODE ENDED?
Patent AU-2013229186-A1 (AU)
Title: Size-based analysis of fetal DNA fraction in maternal plasma
Inventor: LO YUK MING DENNIS
IPC: G16B30/10
Filed: 2013-03-08
Abstract: A fractional concentration of clinically-relevant DNA in a mixture of DNA from a biological sample is determined based on amounts of DNA fragments at multiple sizes. For example, the fractional concentration of fetal DNA in maternal plasma or tumor DNA in a patient's plasma can be determined. The size of DNA fragments in a sample is shown to be correlated with a proportion of fetal DNA and a proportion of tumor DNA, respectively. Calibration data points (e.g., as a calibration function) indicate a correspondence between values of a size parameter and the fractional concentration of the clinically-relevant DNA. For a given sample, a first value of a size parameter can be determined from the sizes of DNA fragments in a sample. A comparison of the first value to the calibration data points can provide the estimate of the fractional concentration of the clinically-relevant DNA.
Patent AU-2013234396-A1 (AU)
Title: Protection of progenitor cells and regulation of their differentiation
Inventor: GHOSH PETER
IPC: A01N1/00
Filed: 2013-09-27
Abstract: Abstract The present invention relates to the use of polysulfated polysaccharides in combination with progenitor cells to improve the viability of the progenitor cells including improving the cryopreservation of the progenitor cells and provides novel 5 compositions, methods and uses. The present invention also relates to the use of polysulfated polysaccharides to regulate the proliferation and differentiation of progenitor cells.
Patent AU-2013242166-A1 (AU)
Title: A medical device having a surface comprising antimicrobial metal
Inventor: ARVIDSSON ANNA
IPC: A61C8/00
Filed: 2013-03-13
Abstract: A medical device intended for contact with living tissue comprises a substrate having a surface, which surface comprises a layer comprising one or more compound(s)of at least one non-toxic post-transition metal, such as a gallium or bismuth compound.A layer comprising a compound of at least one non-toxic post-transition metal has been shown to inhibit biofilm formation on the surface of the medical device, which may reduce the risk for infection e.g. around a dental implant. A method of producing the medical device comprises: a) providing a substrate having a surface; and applying a compound of at least one non-toxic post-transition metal onto said surface to form a layer, e.g. using a thin film deposition technique.
Patent AU-2013257335-A1 (AU)
Title: Anthelmintic compositions
Inventor: HARRISON GARY ROBERT
IPC: A61K47/30
Filed: 2013-05-01
Abstract: The invention relates to anthelmintic compositions, their preparation and their use. More particularly the invention relates to an anthelmintic composition including micronized macrocyclic lactone particles and water. The invention also more particularly relates to method of manufacturing an anthelmintic composition including the step of suspending micronized macrocyclic lactone particles in water.
Patent AU-2013259087-A1 (AU)
Title: Communication control device, communication control method, and terminal device
Inventor: TAKANO HIROAKI
IPC: H04W16/30
Filed: 2013-03-13
Abstract: [Problem] To suppress interference between related cells while improving throughput in a wireless communication system employing TDD. [Solution] There is provided a communication control device provided with: a wireless communication unit for communicating with one or more terminal devices in a cell over a channel capable of dynamically configuring a link direction for each subframe, which is a unit of time in wireless communications; and a control unit for controlling the allocation of communication resources to the terminal device on the basis of the configuration of the channel link direction and the location of the terminal device in the cell.
Patent AU-2013279597-A1 (AU)
Title: Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
Inventor: VAN T KLOOSTER GERBEN ALBERT ELEUTHERIUS
IPC: A61K45/06
Filed: 2013-06-10
Abstract: The present invention relates to the novel medical use of the compound according to Formula I, in particular in the treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons. In particular, the compound inhibits JAK a family of tyrosine kinases, and more particularly JAK1. The present invention also provides pharmaceutical compositions comprising the compound, methods for the prophylaxis and/or treatment of diseases involving inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons by administering the compound.
Patent AU-2013297845-A1 (AU)
Title: Conveyance vehicle surveillance device
Inventor: ISHIMOTO HIDEFUMI
IPC: G08B25/00
Filed: 2013-05-23
Abstract: An objective of the present invention is, on the basis of an image from a camera which is disposed in a conveyance vehicle, to have an operator accurately recognize a circumstance under a vessel of the conveyance vehicle, and a circumstance to the rear thereof. This conveyance vehicle surveillance device comprises: a lamp part (13) which is below a vessel (4) of a dump truck (1) and is attached on a rear end of a frame (3) of the dump truck (1); a rear view camera (10B) which is disposed above the lamp part (13), includes in a field of view thereof at least a portion of an axle (11) of rear wheels (6) of the dump truck (1), and photographs an area to the rear of the dump truck (1) with an optical axis obliquely downward; a screen (16) which is disposed between the lamp part (13) and the rear camera (10B), and which extends to a location included in the field of view of the rear view camera (10B) wherein at least a portion of the axle (11) is included in the field of view; and a monitor (24) which is provided in a driver compartment (2) of the dump truck (11), and which displays a rear view camera image which the rear view camera (10B) photographs.
Patent AU-2013300083-A1 (AU)
Title: Thermal diagnostic for single-crystal process fluid pressure sensor
Inventor: HEDTKE ROBERT C
IPC: G01L27/00
Filed: 2013-06-21
Abstract: A method (150) of verifying a condition of a single-crystal pressure sensor (100) is provided. The method (150) includes providing a single-crystal pressure sensor (100) that has at least one electrical characteristic that varies with applied pressure being coupled to a first output and a second output. The pressure sensor (100) also has at least one resistive element therein. A current is applied through the resistive element (122) to heat (152) the pressure sensor (100). At least one output of the pressure sensor (100) is monitored (154) to determine a response of the pressure sensor (100) to current-induced heat. A verification output is provided (156) based on the response.
Patent AU-2013312113-A1 (AU)
Title: Composition of HMB and ATP and methods of use
Inventor: BAIER SHAWN
IPC: A61K31/7076
Filed: 2013-09-10
Abstract: The present invention provides a composition comprising HMB and ATP. Methods of administering HMB and ATP to an animal are also described. HMB and ATP are administered to increase power and strength. The combination of HMB and ATP together has a synergistic effect, which results in a surprising and unexpected level of improvement in power and strength. HMB and ATP are also administered to increase lean body mass and muscle hypertrophy and to prevent typical declines in performance that are characteristic of overreaching.
Patent AU-2013318632-A1 (AU)
Title: Method and system for treatment of biological tissue
Inventor: MATHENY ROBERT G
IPC: A61K35/38
Filed: 2013-05-29
Abstract: A composition for reconstmction, replacement or repair of damaged or diseased biological tissue comprising an extracellular matrix (ECM) composition that includes an ECM scaffold component derived from a mammalian source and at least one additional bioactive component selected from the group consisting of a statin and a chitin derivative.
Patent AU-2013329356-A1 (AU)
Title: Systems and methods for tumor clonality analysis
Inventor: SANBORN JOHN ZACHARY
IPC: G16B45/00
Filed: 2013-11-07
Abstract: Systems and methods of genomic analysis are presented that provide a framework to determine a tumor's clonality, the number and proportion of all major clones, and the variants that distinguish them. Contemplated systems and methods also allow phasing mutations to parental alleles to so time their emergence within the population of tumor cells, and provide an accurate estimate of the amount of contaminating normal tissue that was present in the tumor biopsy.
Patent AU-2013332012-A1 (AU)
Title: Building system, particularly a residential building
Inventor: TER HUURNE ANDRE
IPC: E04B2/96
Filed: 2013-09-12
Abstract: The invention relates to a building system, particularly a residential building, with a skeleton structure consisting of posts (14) and crossbeams (24) erected on a ground slab (9), wherein the skeleton fields are provided with typified filling panels (10), windows (12) and doors (20). According to the invention: - the filling panels are arranged in a substantially flush manner between the posts and the crossbeams; - the filling panels (10) comprise multiple layers, with an inner cover panel (17), an outer cover panel (16) and frame strips (29) running between the inner cover panel (17) and the outer cover panel (16) with insulation (15) enclosed therebetween; - connecting means (30) designed as detachable fittings are provided in the skeleton fields for connecting the posts (14) and the crossbeams (24) to the filling panels (10) arranged flushly therewith; - each outer edge of the outer cover panel (16) of each filling panel (10) overlaps the adjacent post (14) or crossbeam (24) at least in part; and - the connecting means (30) clamp the regions of the outer cover panel (16) that overlap the posts (14) or crossbeams (24) to the posts (14) or crossbeams (24).
Patent AU-2013348216-A1 (AU)
Title: Novel compounds
Inventor: COE DIANE MARY
IPC: A61K31/519
Filed: 2013-11-18
Abstract: Compounds of formula (I) and salts thereof wherein R
Patent AU-2013359253-A1 (AU)
Title: Electric latch retraction device for vertical rod door latches
Inventor: ELLER DARREN C
IPC: E05B63/06
Filed: 2013-12-12
Abstract: An electric latch retraction device for vertical rod door latches includes an automatic adjustment feature including a limit switch and a linear sensor, such as a Hall effect sensor, which detects vertical position. A microcontroller monitors the vertical position of a pivoting retraction lever driven at the pivot by a linear driver. The housing for the electric latch retraction device is preferably external to the door and one end of the retraction lever extends into the door to drive a vertical rod door latch mechanism while an opposed end contacts the limit switch to signal that continued driving of the linear driver will begin to drive the vertical rod door latch. The microcontroller determines from the vertical position of the retraction lever when the limit switch is actuated whether the electric latch retraction device is mounted too high or too low.
Patent AU-2014200960-A1 (AU)
Title: An improved dry powder drug delivery system
Inventor: SMUTNEY CHAD C
IPC: A61K9/72
Filed: 2014-02-24
Abstract: A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, peptides and proteins such as insulin and glucagon -like peptide 1 for the treatment of endocrine disease, for example, diabetes and/or obesity. WO 2010/102148 PCT/US2O1O/026271
Patent AU-2014202130-A1 (AU)
Title: Gaming machine capable of repeatedly executing a unit game
Inventor: FUJISAWA MASUMI
IPC: A63F13/00
Filed: 2014-04-16
Abstract: A gaming machine that is capable of imparting diversified variations to the play of a bonus game is provided. A main CPU displays a selection screen in a case 5 where a feature game trigger is established, and causes a player to select one of a free game and a roulette game. In a case where the free game is selected, a total of values of BONUS symbols that correspond to the feature game trigger is determined as the number of free games. On the other hand, in a case where the roulette game is selected, a game is completed by carrying out roulette game processing once, and the amount of 10 payouts is determined based on the number of free games. The free game and the roulette game are respectively set so that expectation values of the number of payouts are equal to each other. SYMBOLS # PREDETERMINED CONDITION PREDETERMINED CONDITION) COMPLETION OF FREE GAME COMPLETION OF (REMAINING NUMBER OF ROULETTE GAME GAMES = 1) SELECTING SELECTING ROULETTE FREE GAME GAME FREE GAME 'REPEATING UNIT GAME (REMAINING NUMBER OF GAMES > 0) -ADDING THE NUMBER OF (SYMBOLS = PREDETERMINED CONDITION)
Patent AU-2014203385-A1 (AU)
Title: Slot interface access unit, method thereof, and program thereof, as well as redundancy configuration of main unit, and replacing method of the same
Inventor: HIKABE AKINORI
IPC: H04L45/586
Filed: 2014-06-23
Abstract: - 43 A single main unit manages information on hardware resources and the like of all main units connected to a network in an integrated fashion. A 5 slot management module, a slot control module, and a physical slot/managed slot comparison table are provided between an input/output control module and a slot interface subordinate thereto. The input/output control module accesses the slot interface by using virtual slot identification information. The slot management module refers to the physical slot/managed slot 10 comparison table, converts the virtual slot identification information into physical slot identification information, and accesses a slot control module corresponding to the physical slot identification information obtained by the conversion, thereby realizing a physical access of the input/output control module to the slot interface.
Patent AU-2014205422-A1 (AU)
Title: Odor control bulk material cover
Inventor: DONZE JOSEPH
IPC: C09D7/63
Filed: 2014-01-09
Abstract: An odor suppressing cover material for a bulk material pile and method for applying the cover material are disclosed. The cover composition includes at least 50 weight percent water; 1 to 50 weight percent of a bentonite clay; 0.1% to 5% cellulosic water dispersible polymer or starch; and 0.02% to 1% of a mixture containing at least some lipid essential oil and at least some ethoxylated alkylphenol. The cover composition may additionally and optionally contain Portland cement, colorant and fibers.
Patent AU-2014211856-A1 (AU)
Title: Substituted 2-aminopyridine protein kinase inhibitor
Inventor: XIAO DENGMING
IPC: C07D213/73
Filed: 2014-01-27
Abstract: Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, preparation method and pharmaceutical composition thereof. Also disclosed are uses of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing protein kinase-related diseases.
Patent AU-2014259652-A1 (AU)
Title: Unleaded gasoline formulations including mesitylene and pseudocumene
Inventor: D ACOSTA CHRIS
IPC: C10L1/10
Filed: 2014-05-02
Abstract: The present invention provides an unleaded, piston engine fuel formulation comprising a blend of mesitylene, pseudocumene and isopentane having a MON of at least 94 and an RVP of 38 to 49 kPa at 37.8°C. In certain aspects, the formulation comprises specific weight percentages of each of the mesitylene, pseudocumene and isopentane components, and varying MON ratings. In additional aspects, the formulations comprise a combination of mesitylene, isopentane, and one or more additional components selected from the group consisting of pseudocumene, toluene and xylenes. In certain embodiments, the formulations also include alkylates and or alkanes. The formulations have unusually high MON ratings, and desirable RVP and distillation curve characteristics for formulations not including additional components, particularly octane boosters.
Patent AU-2014268511-A1 (AU)
Title: Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites to enhance positive response in a mammal
Inventor: DAVENPORT GARY MITCHELL
IPC: A23L33/00
Filed: 2014-05-22
Abstract: The present invention relates to a use of composition comprising a glucose anti-metabolite and/or source of glucose anti-metabolite in a method of enhancing a positive affect and/or energetic arousal in a mammal.
Patent AU-2014273794-A1 (AU)
Title: Production of pulse protein products with reduced astringency
Inventor: SCHWEIZER MARTIN
IPC: A23L11/30
Filed: 2014-05-30
Abstract: Pulse proteins of reduced astringency are obtained by fractionating pulse protein products which are completely soluble and heat stable in aqueous media at acid pH value of less than about 4.4 into lower molecular weight, less astringent proteins and higher molecular weight, more astringent proteins.
Patent AU-2014275198-A1 (AU)
Title: Novel compounds and uses thereof
Inventor: ASKEW BEN C
IPC: C07D487/04
Filed: 2014-05-30
Abstract: The present invention provides novel compounds of any one of Formulae (I)-(IV), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of any one of Formulae (I)-(IV) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor signaling pathway (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.
Patent AU-2014280942-A1 (AU)
Title: A process for the identification and preparation of a (r)-specific omega-transaminase
Inventor: HOEHNE MATTHIAS
IPC: C12N9/88
Filed: 2014-12-24
Abstract: The present invention relates to processes for the screening, preparation and characterization of (R)-selective w-transaminases, to transaminases obtained thereby and their uses in various transamination processes.
Patent AU-2014284078-A1 (AU)
Title: New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis
Inventor: MOREAU ALAIN
IPC: A61K31/135
Filed: 2014-06-17
Abstract: Methods of stratifying a subject having or at risk for developing adolescent idiopathic scoliosis (AIS) into diagnostically or clinically useful subclasses are provided. The stratification is based on the subject's ΡΤΡμ expression and/or activity and/or PIPK1γ expression and/or activity. Also provided are methods of predicting the risk of developing a scoliosis also based on the subject's ΡΤΡμ expression and/or activity and/or PIPK1γ expression and/or activity; and methods of increasing GiPCR signaling in cells of a subject in need thereof comprising administering to the subject's cells an effective amount of an inhibitor of PIPK1γ tyrosine phosphorylation; an activator of PIPK1Y tyrosine dephosphorylation; and/or an inhibitor of PIPK1γ expression and/or activity.
Patent AU-2014290201-A1 (AU)
Title: System and method for efficient power distribution and backup
Inventor: JAIN DEEPAK
IPC: H02J9/06
Filed: 2014-07-15
Abstract: A system and method of power distribution and backup is provided. The power backup system includes a first uninterruptible power supply 106(1) and a second uninterruptible power supply 106(2) configured to drive a load 110(1) in parallel. The first uninterruptible power supply and the second uninterruptible power supply are both connected through a direct connection or through at least two switches to at least two power sources 102, 104.